Flex Pharma, Inc. Human Resources Contracts & Agreements
26 Contracts & Agreements
- Bonus & Incentive Agreements (4 contracts)
- Compensation Agreements (3)
- Consulting Agreements (1)
- Employment Agreements (16)
- Separation Agreements (2)
- Salarius Pharmaceuticals, Inc., 2015 Equity Incentive Plan, as amended (Filed With SEC on June 19, 2020)
- Employment Agreement between Mark J. Rosenblum and Salarius Pharmaceutical, Inc., dated April 24, 2020 (Filed With SEC on April 29, 2020)
- Separation and Release Agreement between Scott Jordan and the Registrant, dated March 18, 2020 (Filed With SEC on March 23, 2020)
- Consulting Agreement between Bruce McCreedy and the Registrant, dated March 6, 2020 (Filed With SEC on March 23, 2020)
- Amendment to Second Amended and Restated Executive Employment Agreement dated as of September 10, 2019, by and among Salarius Pharmaceuticals, Inc., Salarius Pharmaceuticals, LLC,... (Filed With SEC on September 16, 2019)
- Amendment to Amended and Restated Executive Employment Agreement dated as of September 10, 2019, by and among Salarius Pharmaceuticals, Inc., Salarius Pharmaceuticals, LLC, and... (Filed With SEC on September 16, 2019)
- Offer of Employment with Salarius Pharmaceuticals, Inc. dated as of September 10, 2019, by and between Salarius Pharmaceuticals, Inc. and Mark Rosenblum (Filed With SEC on September 16, 2019)
- Amended and Restated Executive Employment Agreement, dated February 5, 2019, between David J. Arthur and Salarius Pharmaceuticals, LLC (Filed With SEC on February 14, 2019)
- Second Amended and Restated Executive Employment Agreement, dated February 6, 2019, between Scott Jordan and Salarius Pharmaceuticals, LLC (Filed With SEC on February 14, 2019)
- Amendment to Executive Employment Agreement, effective as of June 20, 2018, by and between the Registrant and William McVicar (Filed With SEC on August 1, 2018)
- Amendment to Executive Employment Agreement, effective as of June 20, 2018, by and between the Registrant and John McCabe (Filed With SEC on August 1, 2018)
- Separation Agreement, effective as of June 26, 2018, by and between the Registrant and Thomas Wessel (Filed With SEC on August 1, 2018)
- Amended and Restated Executive Employment Agreement, effective as of August 1, 2017, by and between the Registrant and William McVicar (Filed With SEC on November 6, 2017)
- AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 11, 2017)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on April 5, 2017)
- FLEX PHARMA, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY AS REVISED ON JANUARY 18, 2017 (Filed With SEC on March 8, 2017)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 8, 2016)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 8, 2016)
- 1 EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on September 9, 2015)
- FLEX PHARMA, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY AS REVISED ON JUNE 29, 2015 (Filed With SEC on August 5, 2015)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on June 2, 2015)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on June 2, 2015)
- FLEX PHARMA, INC. 2015 EQUITY INCENTIVE PLAN OPTION AGREEMENT (INCENTIVE STOCK OPTION OR NONSTATUTORY STOCK OPTION) (Filed With SEC on March 24, 2015)
- FLEX PHARMA, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on January 13, 2015)
- FLEX PHARMA, INC. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: [ ], 2015 APPROVED BY THE STOCKHOLDERS: [ ], 2015 IPO DATE: [ ], 2015 (Filed With SEC on January 13, 2015)
- FLEX PHARMA, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: MARCH 21, 2014 APPROVED BY THE STOCKHOLDERS: MARCH 21, 2014 AMENDED BY THE BOARD OF DIRECTORS:... (Filed With SEC on December 29, 2014)
